SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Directorate Change

21 Jun 2018 13:00

RNS Number : 1687S
TP ICAP PLC
21 June 2018
Β 

TP ICAP appoints Lorraine Trainer as Non-Executive Director

Β 

[London, 21 June 2018] - TP ICAP plc, the world's largest interdealer broker, is pleased to announce the appointment of Lorraine Trainer to the role of Non-Executive Director and as a member of the company's Remuneration, Audit and Nominations and Governance Committees. She will assume the positions with effect from 1 July 2018. As indicated in the 2017 Annual Report, Stephen Pull, Chairman of the Remuneration Committee, will be retiring from the Board in the first few months of 2019. Lorraine will take over as Chairman of the Remuneration Committee at that time.

Β 

Ms. Trainer has had an established career in HR leadership across financial institutions including Citibank NA, London Stock Exchange and Coutts NatWest Group, before setting up the mentoring business at Manchester Square Partners. She also spent time at De Beers LV Ltd focusing on human resources and customer experience. Ms. Trainer is currently a Non-Executive Director and member of the Board Nominations and Remuneration Committee of Sonae, one of the largest family-owned listed companies in Portugal, with interests in shopping centres, food, sport and fashion retail and media and telecommunications; and a Non-Executive Director and Chair of the Remuneration Committee at Essentra, a leading global provider of essential components and packaging. Ms. Trainer has previously served as the Senior Independent Director and Chair of the Remuneration Committee at Jupiter Fund Management, and as a Non-Executive Director and Chair of the Remuneration Committee at Colt Group and Aegis Group.

Β 

Commenting on Ms. Trainer's appointment, Rupert Robson, Chairman of TP ICAP, said: "We are very pleased to welcome Lorraine to the Board of TP ICAP. She brings substantial experience, both from her executive career, as well as from her directorship roles, and will be a great addition to our Board."

Β 

TP ICAP plc confirms that there are no other details that are required to be disclosed under 9.6.13R of the Listing Rules of the Financial Conduct Authority.

Β 

- Ends -

Β 

Enquiries:

Β 

Jamie Dunkley, Group Media Relations Director

+44 (0) 20 7200 7524

Β 

Brian Buckley / Eilis Murphy, Brunswick

+44 (0) 20 7404 5959

Β 

About TP ICAP

Β 

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data &; analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

Β 

www.tpicap.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOAEAFKFALAPEFF
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20262:25 pmRNSDirector/PDMR Shareholding
22nd May 202612:45 pmRNSHolding(s) in Company
13th May 20264:12 pmRNSResult of AGM
13th May 20264:12 pmRNSDirectorate change
13th May 20267:00 amRNSTrading Statement
5th May 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20269:00 amRNS2025 Annual Report and Notice of 2026 AGM
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20269:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:05 amRNSLaunch of sixth share buyback programme of £80m
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
5th Nov 20257:00 amRNSTrading Statement
2nd Oct 202510:15 amRNSDirector Declaration
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 202510:30 amRNSHolding(s) in Company
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202510:30 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20255:50 pmRNSHolding(s) in Company
22nd Aug 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.